{"id":"https://openalex.org/W2135583595","doi":"https://doi.org/10.1001/jamainternmed.2014.946","title":"Bleeding Risk of Patients With Acute Venous Thromboembolism Taking Nonsteroidal Anti-Inflammatory Drugs or Aspirin","display_name":"Bleeding Risk of Patients With Acute Venous Thromboembolism Taking Nonsteroidal Anti-Inflammatory Drugs or Aspirin","alternate_titles":[],"publication_year":2014,"publication_date":"2014-04-14","ids":{"openalex":"https://openalex.org/W2135583595","doi":"https://doi.org/10.1001/jamainternmed.2014.946","mag":"2135583595","pmid":"https://pubmed.ncbi.nlm.nih.gov/24733305"},"language":"en","primary_location":{"id":"doi:10.1001/jamainternmed.2014.946","doi":"https://doi.org/10.1001/jamainternmed.2014.946","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jamainternmed.2014.946","pdf_url":null,"source":{"id":"https://openalex.org/S65364685","display_name":"JAMA Internal Medicine","issn_l":"2168-6106","issn":["2168-6106","2168-6114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Internal Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2135583595"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://cris.maastrichtuniversity.nl/en/publications/06dd303f-a63a-4874-9e98-5ea2c98a2065","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108087183","display_name":"Bruce L. Davidson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bruce L. Davidson","raw_affiliation_strings":["Division of Pulmonary and Critical Care Medicine; University of Washington School of Medicine; Seattle Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pulmonary and Critical Care Medicine; University of Washington School of Medicine; Seattle Washington","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000118081","display_name":"Sara Verheijen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sara Verheijen","raw_affiliation_strings":["University of Amsterdam, the Netherlands","University of Amsterdam The Netherlands#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I887064364"]},{"raw_affiliation_string":"University of Amsterdam The Netherlands#TAB#","institution_ids":["https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110204919","display_name":"Anthonie W.A. Lensing","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anthonie W. A. Lensing","raw_affiliation_strings":["Bayer Healthcare, Wuppertal, Germany4Academic Medical Centre, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Healthcare, Wuppertal, Germany4Academic Medical Centre, Amsterdam, the Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081944182","display_name":"Martin Gebel","orcid":"https://orcid.org/0000-0003-0812-8490","observed_orcids":["https://orcid.org/0000-0003-0812-8490"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martin Gebel","raw_affiliation_strings":["Bayer Healthcare, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Healthcare, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014332529","display_name":"Timothy Brighton","orcid":"https://orcid.org/0000-0002-0742-3079","observed_orcids":["https://orcid.org/0000-0002-0742-3079"]},"institutions":[{"id":"https://openalex.org/I4210108821","display_name":"Prince of Wales Hospital","ror":"https://ror.org/022arq532","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210108821"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Timothy A. Brighton","raw_affiliation_strings":["Haematology Division, Prince of Wales Hospital, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haematology Division, Prince of Wales Hospital, Sydney, Australia","institution_ids":["https://openalex.org/I4210108821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025294989","display_name":"Roger M. Lyons","orcid":"https://orcid.org/0000-0001-6508-8080","observed_orcids":["https://orcid.org/0000-0001-6508-8080"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Roger M. Lyons","raw_affiliation_strings":["Cancer Care Centers of South Texas/US Oncology, San Antonio, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Care Centers of South Texas/US Oncology, San Antonio, Texas","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024511887","display_name":"Jeffrey Rehm","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeffrey Rehm","raw_affiliation_strings":["Pulmonary Associates of Fredericksburg, Fredericksburg, Virginia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary Associates of Fredericksburg, Fredericksburg, Virginia","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111455603","display_name":"Martin H. Prins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800191616"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martin H. Prins","raw_affiliation_strings":["Maastricht University Medical Centre, Maastricht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maastricht University Medical Centre, Maastricht, the Netherlands","institution_ids":["https://openalex.org/I2800191616"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":19.733,"has_fulltext":false,"cited_by_count":152,"citation_normalized_percentile":{"value":0.9952866,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"174","issue":"6","first_page":"947","last_page":"947"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venous-thromboembolism","display_name":"venous thromboembolism","score":0.9810000061988831},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.7400000095367432},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.9639999866485596},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/rivaroxaban","display_name":"rivaroxaban","score":0.9210000038146973},{"id":"https://openalex.org/keywords/enoxaparin","display_name":"enoxaparin","score":0.984000027179718},{"id":"https://openalex.org/keywords/vitamin-k-antagonists","display_name":"vitamin K antagonists","score":0.8460000157356262},{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.8119999766349792},{"id":"https://openalex.org/keywords/concomitant-drug-use","display_name":"concomitant drug use","score":0.6759999990463257},{"id":"https://openalex.org/keywords/major-bleeding","display_name":"major bleeding","score":0.8669999837875366},{"id":"https://openalex.org/keywords/clinically-relevant-bleeding","display_name":"clinically relevant bleeding","score":0.9290000200271606},{"id":"https://openalex.org/keywords/deep-vein-thrombosis","display_name":"deep vein thrombosis","score":0.9620000123977661},{"id":"https://openalex.org/keywords/pulmonary-embolism","display_name":"pulmonary embolism","score":1.0}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9749485850334167},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.8248370885848999},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.7231515645980835},{"id":"https://openalex.org/C2778205648","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Anticoagulant","level":2,"score":0.5979344248771667},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5196134448051453},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4964218735694885},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.4928562641143799},{"id":"https://openalex.org/C2776265017","wikidata":"https://www.wikidata.org/wiki/Q220570","display_name":"Pulmonary embolism","level":2,"score":0.455024778842926},{"id":"https://openalex.org/C2776704044","wikidata":"https://www.wikidata.org/wiki/Q2852541","display_name":"Vitamin K antagonist","level":4,"score":0.4340498745441437},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.41315871477127075},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4038435220718384},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3469683825969696},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.31990084052085876},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.093924880027771}],"mesh":[{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017984","descriptor_name":"Enoxaparin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054556","descriptor_name":"Venous Thromboembolism","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D054556","descriptor_name":"Venous Thromboembolism","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1001/jamainternmed.2014.946","doi":"https://doi.org/10.1001/jamainternmed.2014.946","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jamainternmed.2014.946","pdf_url":null,"source":{"id":"https://openalex.org/S65364685","display_name":"JAMA Internal Medicine","issn_l":"2168-6106","issn":["2168-6106","2168-6114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Internal Medicine","raw_type":"journal-article"},{"id":"pmid:24733305","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24733305","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA internal medicine","raw_type":"Comparative Study"},{"id":"pmh:oai:cris.maastrichtuniversity.nl:openaire/06dd303f-a63a-4874-9e98-5ea2c98a2065","doi":null,"is_oa":true,"landing_page_url":"https://cris.maastrichtuniversity.nl/en/publications/06dd303f-a63a-4874-9e98-5ea2c98a2065","pdf_url":null,"source":{"id":"https://openalex.org/S4306402616","display_name":"Research Publications (Maastricht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I34352273","host_organization_name":"Maastricht University","host_organization_lineage":["https://openalex.org/I34352273"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Davidson, B L, Verheijen, S, Lensing, A W A, Gebel, M, Brighton, T A, Lyons, R M, Rehm, J & Prins, M H 2014, 'Bleeding Risk of Patients With Acute Venous Thromboembolism Taking Nonsteroidal Anti-Inflammatory Drugs or Aspirin', JAMA Internal Medicine, vol. 174, no. 6, pp. 947-953. https://doi.org/10.1001/jamainternmed.2014.946","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:um:oai:cris.maastrichtuniversity.nl:publications/06dd303f-a63a-4874-9e98-5ea2c98a2065","doi":null,"is_oa":true,"landing_page_url":"https://cris.maastrichtuniversity.nl/en/publications/06dd303f-a63a-4874-9e98-5ea2c98a2065","pdf_url":null,"source":{"id":"https://openalex.org/S4306402616","display_name":"Research Publications (Maastricht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I34352273","host_organization_name":"Maastricht University","host_organization_lineage":["https://openalex.org/I34352273"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"JAMA Internal Medicine, 174(6), 947 - 953. AMA","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:cris.maastrichtuniversity.nl:openaire/06dd303f-a63a-4874-9e98-5ea2c98a2065","doi":null,"is_oa":true,"landing_page_url":"https://cris.maastrichtuniversity.nl/en/publications/06dd303f-a63a-4874-9e98-5ea2c98a2065","pdf_url":null,"source":{"id":"https://openalex.org/S4306402616","display_name":"Research Publications (Maastricht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I34352273","host_organization_name":"Maastricht University","host_organization_lineage":["https://openalex.org/I34352273"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Davidson, B L, Verheijen, S, Lensing, A W A, Gebel, M, Brighton, T A, Lyons, R M, Rehm, J & Prins, M H 2014, 'Bleeding Risk of Patients With Acute Venous Thromboembolism Taking Nonsteroidal Anti-Inflammatory Drugs or Aspirin', JAMA Internal Medicine, vol. 174, no. 6, pp. 947-953. https://doi.org/10.1001/jamainternmed.2014.946","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W42860337","https://openalex.org/W84643353","https://openalex.org/W1967937963","https://openalex.org/W1991549653","https://openalex.org/W2026589095","https://openalex.org/W2035545749","https://openalex.org/W2079147756","https://openalex.org/W2090862037","https://openalex.org/W2101081523","https://openalex.org/W2106461600","https://openalex.org/W2113989522","https://openalex.org/W2115787552","https://openalex.org/W2117677020","https://openalex.org/W2118654837","https://openalex.org/W2130199362","https://openalex.org/W2131358454","https://openalex.org/W2143255011","https://openalex.org/W2144471064","https://openalex.org/W2146136250","https://openalex.org/W2338244864","https://openalex.org/W2584234528"],"related_works":["https://openalex.org/W4413346184","https://openalex.org/W4404474242","https://openalex.org/W2990891361","https://openalex.org/W2286914921","https://openalex.org/W2239258381","https://openalex.org/W2008333987","https://openalex.org/W3213026565","https://openalex.org/W2005577861","https://openalex.org/W2143389173","https://openalex.org/W4387857493"],"abstract_inverted_index":{"IMPORTANCE:":[0],"Combined":[1],"anticoagulant":[2,25,42,165,289],"and":[3,26,49,74,88,106,125,131,138,269,276,307],"aspirin":[4,52,107,123,227,256,297],"therapy":[5,53,108],"is":[6,31,298],"associated":[7,299],"with":[8,14,56,81,150,181,211,240,285,300],"increased":[9,302],"bleeding":[10,19,38,129,133,148,176,209,235,271],"risk":[11,20,39,265,303],"in":[12,54,86,90,236,264],"patients":[13,55,92,238,284],"atrial":[15],"fibrillation,":[16],"but":[17],"the":[18,37,69],"of":[21,24,40,65,120,154,185,215,244,293,304],"combined":[22,41],"use":[23,124,166,292],"nonsteroidal":[27],"anti-inflammatory":[28],"drugs":[29],"(NSAIDs)":[30],"poorly":[32],"documented.":[33],"OBJECTIVE:":[34],"To":[35],"estimate":[36],"(rivaroxaban":[43],"or":[44,51,122,296],"enoxaparin-vitamin":[45],"K":[46],"antagonist":[47],"[VKA])":[48],"NSAID":[50,105,121,295],"venous":[57,286],"thromboembolism.":[58],"DESIGN,":[59],"SETTING,":[60],"AND":[61,117,281],"PARTICIPANTS:":[62],"Prospective":[63],"analysis":[64],"observational":[66],"data":[67],"from":[68,94],"EINSTEIN":[70],"deep":[71],"vein":[72],"thrombosis":[73],"pulmonary":[75],"embolism":[76],"clinical":[77],"trials":[78,84],"comparing":[79],"rivaroxaban":[80,275],"enoxaparin-VKA":[82,277],"treatment,":[83,145,206],"performed":[85],"hospitals":[87],"clinics":[89],"8246":[91],"enrolled":[93],"2007":[95],"to":[96,104,111,191,221,250],"2009.":[97],"EXPOSURE:":[98],"Bleeding":[99],"event":[100,130,134,152,183,213,242],"rates":[101,135],"during":[102,164,177,196,226,255],"exposure":[103],"were":[109,272],"compared":[110,190,220,249],"time":[112],"without":[113],"exposure.":[114],"MAIN":[115],"OUTCOMES":[116],"MEASURES:":[118],"Days":[119],"nonuse,":[126],"clinically":[127,146,207,267,305],"relevant":[128,147,208,268,306],"major":[132,270,308],"by":[136],"patient-years,":[137,189,219,248],"hazard":[139],"ratios.":[140],"RESULTS:":[141],"During":[142],"NSAID-anticoagulant":[143,178],"concomitant":[144,205,291],"occurred":[149,180,210,239],"an":[151,182,212,241,294,301],"rate":[153,184,214,243],"37.5":[155],"per":[156,161,187,193,217,223,246,252],"100":[157,162,188,194,218,224,247,253],"patient-years":[158,163,195,225,254],"vs":[159],"16.6":[160],"only":[167],"(hazard":[168],"ratio":[169],"[HR],":[170],"1.77":[171],"[95%":[172,200,231,260],"CI,":[173,201,232,261],"1.46-2.14]).":[174],"Major":[175,234],"treatment":[179],"6.5":[186],"2.0":[192],"nonuse":[197,228,257],"(HR,":[198,229,258],"2.37":[199],"1.51-3.75]).":[202],"For":[203],"aspirin-anticoagulant":[204],"36.6":[216],"16.9":[222],"1.70":[230],"1.38-2.11]).":[233],"aspirin-anticoagulant-treated":[237],"4.8":[245],"2.2":[251],"1.50":[259],"0.86-2.62]).":[262],"Increases":[263],"for":[266,274],"similar":[273],"anticoagulation":[278],"regimens.":[279],"CONCLUSIONS":[280],"RELEVANCE:":[282],"Among":[283],"thromboembolism":[287],"receiving":[288],"therapy,":[290],"bleeding.":[309]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2135583595","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":20},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":19},{"year":2016,"cited_by_count":21},{"year":2015,"cited_by_count":18},{"year":2014,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
